drugset / Trial / NCT02026479

Sudden Hearing Loss Multi-center Clinical Trial

NCT02026479 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The incidence of sudden hearing loss is rising obviously resent year, Glucocorticoids have obtained obvious effect in the treatment of sudden deafness. Postauricular hypodermic injection is the latest findings in clinical work and a new noninvasive way of administration which is gradually expanding research. The aim of this experiment is to verify and explore the efficacy and safety of the postauricular injection treatment with different doses of Glucocorticoids.

Timeline

Start
2014-01
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 5 mg Other
Subject Dexamethasone Small molecule 10 mg Other
Subject Ginaton Unknown 40 mg Oral